Suppressor Cells and the Handling of Antigen

Immunological Reviews

Volumn 50, Issue 1, 1980, Pages 3-45

  Asherson, Geoffrey L ^a   Zembala, Marek ^b   Thomas, Wayne R ^c   Perera, M A C C ^a  

^a MRC Clinical Research Centre   (United Kingdom)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYCLOPHOSPHAMIDE; NITROBENZENE DERIVATIVE; OXAZOLONE; PICRYL CHLORIDE; TRINITROBENZENESULFONIC ACID; DNA; HAPTEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

B LYMPHOCYTE; CONTACT SENSITIVITY; CONTACT SENSITIZATION; IMMUNOSUPPRESSIVE TREATMENT; REVIEW; SKIN; SUPPRESSOR CELL; SURVEY; T LYMPHOCYTE; THYMECTOMY; THYMUS; ANIMAL; BIOSYNTHESIS; CELLULAR IMMUNITY; CONTACT DERMATITIS; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MACROPHAGE;

ANIMAL; ANTIGENS; CYTOTOXICITY, IMMUNOLOGIC; DERMATITIS, CONTACT; DNA; HAPTENS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MACROPHAGES; SKIN; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR; TERMINOLOGY; THYMECTOMY;

EID: 0019227117     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1980.tb00306.x     Document Type: Article

References (121)

1. The passive transfer of delayed hypersensitivity in the guinea‐pig. I. The synergic effect of immune cells and immune serum on the 24‐hour skin reactin and a study of the histology
2. Induction of cell‐mediated immunity in the mouse: circumstantial evidence for highly immunogenic antigen in the regional lymph nodes following skin painting with contact sensitizing agents
3. Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer
4. Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction
5. Anatomical location of cells which mediate contact sensitivity in the lymph nodes and bone marrow
6. T cell suppression of contact sensitivity in the mouse. III. The role of macrophages and the specific triggering of non‐specific suppresion
7. Suppression of contact sensitivity by T cells in the mouse. I. Demonstration that suppressor cells act on the effector stage of contact sensitivity; and their induction following in vitro exposure to antigen
8. Suppressor T cells in cell‐mediated immunity
9. The mechanism of immunological unresponsiveness to picryl chloride and the possible role of antibody mediated depression
10. Control mechanisms of cell mediated immunity; the separate control of net DNA synthesis and of contact sensitivity skin reactions and the role of thymus‐derived cells
11. Passive transfer of contact sensitivity by bone marrow cells and evidence for their origin from immunized lymph nodes
12. In vitro absorption and molecular weight of specific cell suppressor factor
13. Control of the immune response. I. Depression of DNA synthesis by immune lymph node cells
14. Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract
15. Occurrence of suppressor cells in lymph nodes and spleen at later times after immunization with the contact sensitizing agent picryl chloride
16. The production of unresponsiveness in the mouse by feeding contact sensitizing agents and the role of modulator cells in the Peyer's patches, mesenteic lymph nodes and other lymphoid tissues
17. Analysis of the induction phase of contact sensitivity by footpad transfer of regional lymph node cells; macrophages and radioresistant T cells induce immunity
18. The purification of specific anti‐picryl suppressor factor which depresses the passive transfer of contact sensitivity: affinity chromatography on antigen and concanavalin A sepharose and specific elution with hapten and a‐methylmannoside
19. Contact sensitivity and the DNA response in mice to high and low doses of oxazolone; low dose unresponsiveness following painting and feeding and its prevention by pretreatment with cyclophosphamide
20. The production of contact sensitivity by the injection into the footpads of recipients of the lymph node cells from mice 1 day after painting their skin with contact sensitizing agent; requirement for matching at the major histocompatibility complex between donor and recipient mice
21. Contact‐sensitizing agents and the intestinal tract: the production of immunity and unresponsive‐ness by feeding contact‐sensitizing agents and the role of suppressor cells
22. Antibody‐mediated basophil accumulations in cutaneous basophil hypersensitivity reactions of guinea pigs
23. In vivo induction of carrier‐specific cyclophosphamide‐sensitive suppressor cells for cell‐mediated immunity in mice
24. Induction of delayed hypersensitivity by dinitrophenylated lymphocytes
25. Antigen‐laden cells in thoracic duct lymph. Implications for adoptive transfer experiments
26. Immune conservation: a possible consequence of the mechanism of interferon‐induced antibody suppression
27. The‐proliferative response of human lymphocytes to antigen suppressed preferentially by lymphocytes precultured with the same antigens
28. Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion
29. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent
30. The cell‐mediated immune response: interactions of initiator and recruited T lymphocytes
31. Initiator and recruited T lymphocytes are distinct subclasses of T lymphocytes
32. A mechanism for the depression of contact sensitivity with B cell mitogens
33. Suppressor T cells in BCG‐infected mice
34. DNA synthesis in vitro by cells from mice immunized with picryl chloride: effect of injection of immune cells
35. Structure and functional behaviour of veiled cells resembling Langerhans cells present in lymph draining from normal skin and after the application of the contact sensitizing agent, dinitrofluorobenzene
36. Morphology of delayed‐type hypersensitivity reactions in man
37. Suppression of the mixed lymphocyte reaction in man by a soluble T cell factor
38. The cellular control of delayed hypersensitivity to Staphylococcus aureus in mice
39. Thymus‐derived lymphocytes produce an immunologically specific macrophage arming factor
40. Cell interactions in the induction of tolerance: the role of thymic lymphocytes
41. Infectious immunological tolerance
42. Regulation of delayed‐type hypersensitivity. III. Effect of cyclophosphamide on suppressor cells for delayed‐type hypersensitivity to sheep erythrocytes in mice
43. Regulation of delayed‐type hypersensitivity. IV. Antigen‐specific suppressor cells for delayed‐type hypersensitivity induced by lipopolysaccharide and sheep erythrocytes in mice
44. Regulation of specific cell‐mediated cytotoxic response against SV40 induced tumour associated antigens by depletion of suppressor T cells with cyclophosphamide in mice
45. The I‐J subregion codes for determinants on suppressor factor(s) which limit the contact sensitivity response to picryl chloride
46. Mechanisms of regulation of cell‐mediated immune responses. I. Effect of the route of immunization with TNP‐coupled syngeneic cells on the induction and suppression of contact sensitivity to picryl chloride
47. Mechanisms of regulation of cell‐mediated immunity. III. The characterization of azobenzenearsonate‐specific suppressor T‐cell‐ derived suppressor factors
48. Antigen‐specific suppressor factors produced by T cell hybridomas for delayed‐type hypersensitivity
49. Immunological enhancement of tumour homografts in mice
50. Effect of previously injected immune serum and tissue on the survival of tumor grafts in mice
51. B‐cell suppression of delayed hypersensitivity reaction
52. Regulatory role of suppressor T cells in the expression of delayed‐type hypersensitivity in mice. II. Soluble factor from thymic suppressor cells stimulated with antigen in vitro and its possible interaction with macrophages
53. Suppressor cells induced in vitro. III. Antigen‐specific suppression by supernatants of suppressor cells
54. Suppressor cell induction in vitro. VI. Production of suppressor factors to synthetic polypeptides GAT and (T, G)‐A–L from cells of responder and nonresponder mice
55. Regulation of delayed‐type hypersensitivity. I. T. suppressor cells for delayed‐type hypersensitivity to sheep erythrocytes in mice
56. Specific suppressor factor for delayed‐type hypersensitivity to sheep erythrocytes in mice
57. Recruitment of effector lymphocytes by initiator lymphocytes: in vivo migration of in vitro sensitized initiator T lymphocytes
58. Suppressor T cell memory
59. Immunologic unresponsiveness appearing after topical application of contact sensitizer in the guinea pig
60. A sensitive assay for cellular hypersensitivity based on the uptake of radioactive colloidal gold
61. Cyclophosphamide intensified the acquisition of allergic contact dermatitis in mice rendered B‐cell deficient by heterologous anti‐IgM antisera
62. Role of major histocompatibility complex gene products in delayed‐type hypersensitivity
63. The induction of hapten‐specific T cell tolerance by using hapten‐modified lymphoid cells. I. Characteristics of tolerance induction
64. Suppressor T cell mechanisms in contact sensitivity. I. Efferent blockade by syninduced suppressor cells
65. Suppressor T cell mechanisms in contact sensitivity. II. Afferent blockade by alloinduced suppressor T cells
66. Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance
67. Soluble factors in tolerance and contact sensitivity to DNFB in mice. I, Suppression of contact sensitivity by soluble suppressor factor (SSF): release in vitro by lymph node cell population containing specific suppressor cells
68. Tolerance and contact sensitivity to DNFB in mice. VII. Functional demonstration of cell‐associated tolerogen in lymph node cell populations containing specific suppressor cells
69. Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T‐cell population in delayed hypersensitivity
70. The influence of IgE‐mediated reactions on the expression of delayed hypersensitivity in the rat
71. Regulation of the immune response to tumor antigens. IV. Tumor antigen specific suppressor factor(s) bear I‐J determinants and induce suppressor T cells in vivo
72. In vitro sensitization to dinitrochlorobenzene in guinea pigs
73. Non‐specific macrophage suppressor factor: its role in the inhibition of contact sensitivity to picryl chloride by specific T suppressor factor
74. Modulation of cellular‐immune responses in vivo and in vitro by histamine receptor‐bearing lymphocytes
75. Cyclophosphamide sensitive T lymphocytes suppress the in vivo generation of antigen‐specific cytotoxic T lymphocytes
76. Increased production and expression of tissue thromboplastin‐likeprocoagulant activity acting In vitro by allogeneic‐ ally stimulated human leukocytes
77. Modulation of age‐related development of contact sensitivity in mice by adult thymectomy
78. The cellular infiltrate in contact hypersensitivity to picryl chloride in the mouse
79. Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide
80. Contact sensitivity in the pig. II. Induction by intralymphatic infusion of DNP conjugated cells
81. The late phase of the immediate wheal and flare skin reaction: its dependence of IgE antibodies
82. Suppressor cells induced by purified protein derivative of tuberculin (PPD): the suppression is mediated by cells that proliferate in response to stimulation with PPD
83. In vivo sensitization of T cells to hapten conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes
84. Regulation of autoimmunization to encephalitogenic myelin basic protein by macrophage‐associated and soluble antigen
85. Sequential interaction of macrophages, initiator T lymphocytes and recruited T lymphocytes in a cell‐mediated immune response to soluble antigen
86. Production of a hapten‐specific macrophage arming factor
87. Suppressor T cells in low zone of tolerance. I. Mode of action of suppressor cells
88. Immune suppression with optimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide
89. Active suppression of l‐fluoro‐2,4‐dinitrobenzene‐immune T cells: requirement of an auxiliary T cell induced by antigen
90. Cytotoxicity in picryl chloride painted mice is enhanced by pretreatment with cyclophosphamide
91. Suppressor T cells which block the induction of cytotoxic T cells in vivo
92. Inhibition of antibody responses by cells from mice treated with picryl sulphonic acid
93. Reaginic antibody to contact sensitizing agents
94. Reaginic antibody to contact sensitizing agents: occurrence of cells which suppress IgG but not reagin responses
95. Induction of contact sensitivity: selective induction of delayed hypersensitivity by the injection of cells from draining lymph nodes into the footpads of normal recipients
96. Suppressor cells for the afferent phase of contact sensitivity to picryl chloride. Inhibition of DNA synthesis induced by T cells from mice injected with picryl sulphonic acid
97. Suppression of antibody responses by cells from mice painted with picryl chloride
98. Antigen‐specific mast cell degranulation in contact sensitivity to picryl chloride ‐ an early event
99. Distribution of immunogenic cells after painting the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations
100. On the mechanism of immunologic self recognition
101. Control mechanism in delayed‐type hypersensitivity
102. Relationship between trinitrophenol and H‐2 antigens on trinitrophenyl‐modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulphonic acid
103. Development of suppressor T‐cells in Mycobacterium habana‐infected mice
104. Control of the immune reaction: T cells in immunized mice which depress the in vivo DNA synthesis response in the lymph nodes to skin painting with the contact sensitizing agent picryl chloride
105. Antibody formation. I. The suppression of antibody formation by passively administered antibody
106. Contact sensitivity in the mouse. V. The role of macrophage cytophilic antibody in passive transfer and the effect of trypsin and anti‐gamma globulin serum
107. Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice
108. The role of T cells in the passive transfer of contact sensitivity and their occurrence in the bone marrow
109. T cell suppression of contact sensitivity in the mouse. II. The role of soluble suppressor factor and its interaction with macrophages
110. The effect of cyclophosphamide and irradiation on cells which suppress contact sensitivity in the mouse
111. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte‐macrophage co‐operation
112. Contact sensitivity to picryl chloride: the occurrence of B suppressor cells in the lymph nodes and spleen of immunized mice
113. Suppressor T cell product which depresses the passive transfer of contact sensitivity shares epitopes with the major histocompatibility complex